Associated Papers
Systematic cysteine scanning identifies a druggable pocket in oncogenic KRAS.
van Tienen LM et al.
Cell Chemical Biology, 2026
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity.
Kwon JJ et al.
Biorxiv : the Preprint Server for Biology, 2024
39484452 (PubMed )
Supplement: media-2.zip › Extended_Data_Tables › Extended_Data_Table_1.xlsx › KRAS_GOF_DMS_Screen
Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer.
Zhao Y et al.
Cell Reports. Medicine, 2024
38964315 (PubMed )
Supplement: mmc3.pdf
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.
Serna-Blasco R et al.
Cancers, 2022
36139605 (PubMed )
Supplement: cancers-14-04446-s001.zip › Supplemental_data_S2.xlsx › dPCR_assays
High-resolution melting for detecting KRAS mutations in colorectal cancer.
Miranda RR et al.
Biomedical Reports, 2019
Mutational analysis of KRAS and its clinical implications in cervical cancer patients.
Jiang W et al.
Journal of Gynecologic Oncology, 2018
Select a paper to view details